We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Trade Groups Question MHRA’s ‘No-Deal’ Brexit Plan
UK Trade Groups Question MHRA’s ‘No-Deal’ Brexit Plan
Two prominent UK drug organizations say they’re “generally supportive” of MHRA’s contingency plans if the UK exits the EU on March 29 without a deal, but expressed concern about orphan drugs and centrally authorized product licenses, among other issues.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor